Bachem Investor Relations Material
Latest events
H2 2024
Bachem
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bachem Holding AG
Access all reports
Bachem Holding AG provides services to the pharmaceutical and biotechnology industries primarily in Switzerland, the United States, Germany, Ireland, the United Kingdom, Austria, Japan, and internationally. It offers peptides as active pharmaceutical ingredients (API) for the treatment of neuronal diseases and various forms of cancer; intermediates for the synthesis of API’s comprising cytotoxic agents to treat various cancers; bioanalytical services for the development or adaptation of assays using mass spectrometry technologies; and hapten labeled peptides for applications in diagnostics and research.
Key slides for Bachem Holding AG
CMD 2024
Bachem Holding AG
H2 2024
Bachem Holding AG
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
BANB
Country
🇨🇭 Switzerland